Member Info for JOHNO77

Not sure about socks or sacks but hopefully a few bags......

They’re share dealing nominees accounts charty. Not II’s.

I am sure AIM regs state that the major shareholders register must be update every 3 months...

The date on top of that still says July 17th..

Mancave. Ticking up as sellers drying up and buyers coming back in sensing we have indeed bottomed out.

IofA collaboration studies are going on in the background, rns of 2nd Oct stated phase 1 of this will test delivery efficacy and will last approx. 4 weeks. Very possible phase 1 results will be rns'ed shortly. If these are successful it will obviously be very good news for us moving forward.

Med collab studies end at approx. the end of this month. We may get an update on this indicating how things have gone. If they do not do so immediately, Med will then have up to 3 months post collab to request an exclusive license to further utilise the data obtained from the studies. Med and N4 can continue to work together but of course the Innovate funding will come to an end.

On top of the above there it is also the chance that further collaborations may be struck with other parties.

I am expecting rns'es as and when, so I think we will have a drip feed into Q4 as opposed to 1 big update.

Cheers, thought so Apple. Knew he had cloned on here but then saw the twitter account too. The twitter account is just full of abuse, he seems like a bit of a wrong'un.

Ok, back to n4p...

Applegarth are you applegarth lse on Twitter??

After the Sildenafil setback I think most have underestimated the upside potential of this Medimmune collaboration.

No hard feelings Artyth, we've all got opinions. Just guessing games atm. Just be careful when accusing people of fraud!

GL

No problem mate.... Even Stig of the dumps.

rub on your gooch then stick under your tongue... looool.

Don't worry I've got some spare arm bands Mazik

None of us have a crystal ball do we which is a shame.

'how could the prospects be so promising beforehand?' agreed with that one ML but I certainly don't think NT is a crook.

I'm certainly not saying N4's the best company ever, Nuvec may indeed fail. I'm just here because of the huge upside if it doesn't. A gamble of course but one i'm prepared to take.

This is where we are until a positive RNS proves otherwise...GLA

Charty you make some good posts on here and by the sounds of it have some great experience but I really do think your imagination gets massively carried away at times....

That's right and I was also about the only one buying at 5.5p 18 months ago.

What an idiot eh?

Artyth, some serious allegations there. Man up for god sake, fraud squad? What planet are you on?

AIM is all abut sentiment and N4P was flying. They've had to reallocate resources now accordingly after very dissapointing results. Nothing was guaranteed was it????

N4P is now focussing on Nuvec as that's where they see the value. NT could have kept stringing the market along with the reform division couldn't he? In business you focus and develop your best selling products, not the turkeys. IMO he's made the correct decision.

If the Meddimune work is a success the SP will again react accordingly won't it?

How do you know they have or haven’t? Don’t you think the army of sellers down to these levels would offset any alleged (by you not me) friends/family buying?

Well ( excuse me , just had to google electroporation lol...) you would hope so... Nanotechnology is the future.

Thanks - your post implied that there were currently testing that vaccine specifically with Nuvec. I guess not then?

All good stuff anyway, cheers.

‘On a side issue I wonder why MI are testing their vaccine which is currently in ph3 trials and likely to be first approved dna vaccine, with nuvec? Answers on a postcard’ Just pricked my ears there Vander... !!! Have you got any tasty links re this phase 3 stage vaccine?? I thought they were using nuvec on an early stage prototype cancer vaccine?

https://uk.news.yahoo.com/astrazeneca-keep-uk-investment-freeze-154648210.html A spokesman for AstraZeneca said Johansson was referring to a freeze on investments in manufacturing announced in 2017. "There has been no change to our investment plans in the UK," the spokesman said.